Drug intelligence / Profile preview

melaleuca alternifolia nanoparticle mouthrinse

Development stage
Unknown
Lead developer
Universidade Federal de Santa Maria
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Topical
01

Overview

This is an experimental mouthrinse formulation containing 0.3% Melaleuca alternifolia (tea tree oil) nanoparticles, developed by researchers at the Universidade Federal de Santa Maria in Brazil. The formulation utilizes nanotechnology, specifically lipid nanoparticles composed of acetyl palmitate as the solid lipid and polysorbate 80 as the surfactant, to deliver the active tea tree oil. It is designed for the treatment of dental plaque and associated gingival inflammation by leveraging the antimicrobial and anti-inflammatory properties of M. alternifolia. In a randomized, double-blind, crossover clinical trial (NCT02695901), the nanoparticle solution was compared to 0.12% chlorhexidine gluconate, demonstrating antimicrobial activity but lower anti-plaque efficacy than the chlorhexidine control, though it showed similar anti-inflammatory effects as measured by gingival crevicular fluid volume.

Other names
0.3% Melaleuca alternifolia nanoparticle solutiontea tree oil nanoparticle mouthrinseMelaleuca alternifolia nanoparticle solution

Beyond the preview

Go deeper on melaleuca alternifolia nanoparticle mouthrinse.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on melaleuca alternifolia nanoparticle mouthrinse.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call